Market Cap 658.20M
Revenue (ttm) 83.33M
Net Income (ttm) -227.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -272.53%
Debt to Equity Ratio 0.00
Volume 461,800
Avg Vol 578,412
Day's Range N/A - N/A
Shares Out 50.51M
Stochastic %K 86%
Beta 1.17
Analysts Strong Sell
Price Target $29.27

Company Profile

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phas...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 552 8181
Address:
9804 Medical Center Drive, Rockville, United States
They_Call_Me_Tater_Salad
They_Call_Me_Tater_Salad Oct. 23 at 10:14 PM
$RGNX Great two months. Very optimistic about the next 6-12.
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Oct. 22 at 1:51 PM
$RGNX Bought the dip. 2-3 week hold $NRXP $BCRX Added for a one month hold. 🛑 loss in place
0 · Reply
waugusti
waugusti Oct. 22 at 12:19 PM
$RGNX i guess the rgnx story ends in 2026 with a buyout by abbvie.
1 · Reply
WaveRB77
WaveRB77 Oct. 22 at 3:37 AM
$RGNX been 6 longyears i clinical trials.The ship gaining speed!!!!!Upon approval in early 26 stock hits $30.00.BY 2028 this stock is $70 dollars a share!!!
0 · Reply
Quantumup
Quantumup Oct. 21 at 2:34 PM
RBC Capital reiterated $FDMT Outperform-$26, and said Boston NDR Strengthens Its Conviction That GTx Will Have a Role in the $15B Retina Market $OCUL $EYPT $REGN KOD $RGNX - ABBV ADVM SNY RBC Capital additionally said:
1 · Reply
Canuckchic
Canuckchic Oct. 18 at 3:34 AM
$RGNX nice after hours spike!
0 · Reply
Lanikai16
Lanikai16 Oct. 18 at 1:16 AM
$RGNX I compared today’s slides (2 year results) to the one year data release from 11/2023. Key findings: Demonstrated sustained or improved Diabetic Retinopathy Severity Scale (DRSS) response at 2 years. Transitioning to pivotal Phase IIb/III trial for NPDR population.
1 · Reply
maphere
maphere Oct. 17 at 9:32 PM
$CLSD $RGNX Here's the presentation slide deck presented today (23 slides) https://www.regenxbio.com/getmedia/7963aa56-bd54-47ae-afbb-9dffff943801/Wykoff_Sura-vec_SCS-ALTITUDE_AAO-2025_FINAL_v1b-12.pdf?ext=.pdf Slidedeck from Aug. 25th (13 slides) https://ir.regenxbio.com/static-files/ec4713fe-ca17-4e07-800b-0fd194153a8c
2 · Reply
chivo12
chivo12 Oct. 17 at 12:24 PM
$RGNX Could be an interesting weekend as it appears that interim ALTITUDE eye data to be shared late this afternoon. I don’t recall any interim data being shared from this study since a presentation at the same annual meeting Friday Nov 3, 2023 when rgnx also issued a PR after the market closed and a con call the following Monday morning. In my opinion, if there is ever to be a parabolic change in the value of this company, it will be driven by this indication/delivery. https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-presentation-american-academy-ophthalmology
2 · Reply
maphere
maphere Oct. 16 at 4:20 PM
$RGNX Regenx and Serepta are arguing over a patent... https://fedcircuitblog.com/2025/10/15/argument-recap-regenxbio-inc-v-sarepta-therapeutics-inc/
2 · Reply
Latest News on RGNX
REGENXBIO to Participate in Upcoming Investor Conferences

Oct 15, 2025, 7:05 AM EDT - 12 days ago

REGENXBIO to Participate in Upcoming Investor Conferences


REGENXBIO Announces Presentation at the World Muscle Society

Sep 29, 2025, 7:05 AM EDT - 4 weeks ago

REGENXBIO Announces Presentation at the World Muscle Society


REGENXBIO Inc. (RGNX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 9:11 AM EDT - 2 months ago

REGENXBIO Inc. (RGNX) Q2 2025 Earnings Call Transcript


REGENXBIO Inc. (RGNX) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:07 AM EDT - 5 months ago

REGENXBIO Inc. (RGNX) Q1 2025 Earnings Call Transcript


5 Reasons To Buy Regenxbio Right Now

Mar 26, 2025, 12:31 PM EDT - 7 months ago

5 Reasons To Buy Regenxbio Right Now


REGENXBIO Inc. (RGNX) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 6:44 PM EDT - 8 months ago

REGENXBIO Inc. (RGNX) Q4 2024 Earnings Call Transcript


Regenxbio: Wet AMD ABBV-RGX-314 Results Remain On Track For 2026

Jan 16, 2025, 4:01 AM EST - 10 months ago

Regenxbio: Wet AMD ABBV-RGX-314 Results Remain On Track For 2026

AMD


Regenxbio Inc.: Why It Is Down, And When It Will Go Up Again

Jan 15, 2025, 3:27 PM EST - 10 months ago

Regenxbio Inc.: Why It Is Down, And When It Will Go Up Again


REGENXBIO Inc. (RGNX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 11:16 PM EST - 1 year ago

REGENXBIO Inc. (RGNX) Q3 2024 Earnings Call Transcript


REGENXBIO Appoints Mitchell Chan as Chief Financial Officer

Sep 17, 2024, 7:05 AM EDT - 1 year ago

REGENXBIO Appoints Mitchell Chan as Chief Financial Officer


They_Call_Me_Tater_Salad
They_Call_Me_Tater_Salad Oct. 23 at 10:14 PM
$RGNX Great two months. Very optimistic about the next 6-12.
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Oct. 22 at 1:51 PM
$RGNX Bought the dip. 2-3 week hold $NRXP $BCRX Added for a one month hold. 🛑 loss in place
0 · Reply
waugusti
waugusti Oct. 22 at 12:19 PM
$RGNX i guess the rgnx story ends in 2026 with a buyout by abbvie.
1 · Reply
WaveRB77
WaveRB77 Oct. 22 at 3:37 AM
$RGNX been 6 longyears i clinical trials.The ship gaining speed!!!!!Upon approval in early 26 stock hits $30.00.BY 2028 this stock is $70 dollars a share!!!
0 · Reply
Quantumup
Quantumup Oct. 21 at 2:34 PM
RBC Capital reiterated $FDMT Outperform-$26, and said Boston NDR Strengthens Its Conviction That GTx Will Have a Role in the $15B Retina Market $OCUL $EYPT $REGN KOD $RGNX - ABBV ADVM SNY RBC Capital additionally said:
1 · Reply
Canuckchic
Canuckchic Oct. 18 at 3:34 AM
$RGNX nice after hours spike!
0 · Reply
Lanikai16
Lanikai16 Oct. 18 at 1:16 AM
$RGNX I compared today’s slides (2 year results) to the one year data release from 11/2023. Key findings: Demonstrated sustained or improved Diabetic Retinopathy Severity Scale (DRSS) response at 2 years. Transitioning to pivotal Phase IIb/III trial for NPDR population.
1 · Reply
maphere
maphere Oct. 17 at 9:32 PM
$CLSD $RGNX Here's the presentation slide deck presented today (23 slides) https://www.regenxbio.com/getmedia/7963aa56-bd54-47ae-afbb-9dffff943801/Wykoff_Sura-vec_SCS-ALTITUDE_AAO-2025_FINAL_v1b-12.pdf?ext=.pdf Slidedeck from Aug. 25th (13 slides) https://ir.regenxbio.com/static-files/ec4713fe-ca17-4e07-800b-0fd194153a8c
2 · Reply
chivo12
chivo12 Oct. 17 at 12:24 PM
$RGNX Could be an interesting weekend as it appears that interim ALTITUDE eye data to be shared late this afternoon. I don’t recall any interim data being shared from this study since a presentation at the same annual meeting Friday Nov 3, 2023 when rgnx also issued a PR after the market closed and a con call the following Monday morning. In my opinion, if there is ever to be a parabolic change in the value of this company, it will be driven by this indication/delivery. https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-presentation-american-academy-ophthalmology
2 · Reply
maphere
maphere Oct. 16 at 4:20 PM
$RGNX Regenx and Serepta are arguing over a patent... https://fedcircuitblog.com/2025/10/15/argument-recap-regenxbio-inc-v-sarepta-therapeutics-inc/
2 · Reply
squiggleburp
squiggleburp Oct. 15 at 8:55 PM
$RGNX strong like bull. The anticipation is building leading up to Februarys PDUFA!!!
1 · Reply
kaos224
kaos224 Oct. 15 at 2:04 PM
0 · Reply
USA_toinfinity_andbeyond
USA_toinfinity_andbeyond Oct. 12 at 9:17 PM
$LAC $CRCL $RGNX $ATOS $MNMD I reckon the market will be back to where it was on Thursday. What do you think?
2 · Reply
Tain0os
Tain0os Oct. 10 at 8:38 PM
$SPY $CSPX (Ireland S&P 500) firm long at the EU open tomorrow. Opened Q4 net longs today -> $RGNX $OMER $INVA $AXGN
1 · Reply
Cashmoneyt
Cashmoneyt Oct. 10 at 5:07 PM
$RGNX $RGNX If it drops below $11 I’m buying up more, waiting until Monday. Already got another 100 shares today. This will be $30+ in a year.
0 · Reply
BRITLS
BRITLS Oct. 10 at 4:15 PM
$RGNX rough
1 · Reply
squiggleburp
squiggleburp Oct. 10 at 12:52 PM
$RGNX Yesterday was a beautiful thing. This stock has had a Northern trajectory since I bought it. I took a bit of profit. Sorry. $14 incoming!
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:53 PM
Keep a close watch on CMCT! $NVT $TPET $RGNX $SPIR ×
0 · Reply
WaveRB77
WaveRB77 Oct. 9 at 1:03 PM
$RGNX Data on phase2 trial ALTITUDE .This study is looking at the results of RGX314 in suprachroidal delivery.
1 · Reply
Doozio
Doozio Oct. 9 at 1:31 AM
$RGNX Thursday 🐑 🎁?
0 · Reply
WaveRB77
WaveRB77 Oct. 8 at 8:01 PM
$RGNX anybody hear any update???
3 · Reply
DarkOrb
DarkOrb Oct. 8 at 5:43 PM
$RGNX Agree. It's trying to break out of a very long base, but we're likely going to need more volume over the next week or two for it to work.
0 · Reply